APA (7th ed.) Citation

Buyse, M., Sargent, D. J., Grothey, A., Matheson, A., & de Gramont, A. (2010). Biomarkers and surrogate end points—the challenge of statistical validation. Nature reviews. Clinical oncology, 7(6), 309-317. https://doi.org/10.1038/nrclinonc.2010.43

Chicago Style (17th ed.) Citation

Buyse, Marc, Daniel J. Sargent, Axel Grothey, Alastair Matheson, and Aimery de Gramont. "Biomarkers and Surrogate End Points—the Challenge of Statistical Validation." Nature Reviews. Clinical Oncology 7, no. 6 (2010): 309-317. https://doi.org/10.1038/nrclinonc.2010.43.

MLA (9th ed.) Citation

Buyse, Marc, et al. "Biomarkers and Surrogate End Points—the Challenge of Statistical Validation." Nature Reviews. Clinical Oncology, vol. 7, no. 6, 2010, pp. 309-317, https://doi.org/10.1038/nrclinonc.2010.43.